Effects of ranitidine and pantoprazole on Ventilator- associated Pneumonia: A randomized double-blind clinical trial

Tanaffos

Volumn 12, Issue 2, 2013, Pages 16-21

  Bashar, Farshid Rahimi ^a   Manuchehrian, Nahid ^a   Mahmoudabadi, Mojtaba ^a   Hajiesmaeili, Mohammad Reza ^b   Torabian, Saadat ^a  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Intensive care unit; Pantoprazole; Randomized controlled trial; Ranitidine; Ventilator associated pneumonia

Indexed keywords

PANTOPRAZOLE; PEPTICARE; RANITIDINE; UNCLASSIFIED DRUG;

ADULT; APACHE; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENDOTRACHEAL INTUBATION; ENTERIC COATED TABLET; FEEDING; FEMALE; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; IRAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; STRESS ULCER; TREATMENT DURATION; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 84883199475     PISSN: 17350344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. du Moulin GC, Paterson DG, Hedley-Whyte J, Lisbon A. Aspiration of gastric bacteria in antacid-treated patients: a frequent cause of postoperative colonisation of the airway. Lancet 1982; 1 (8266): 242-5.
2. Donowitz LG, Page MC, Mileur BL, Guenthner SH. Alteration of normal gastric flora in critical care patients receiving antacid and cimetidine therapy. Infect Control 1986; 7 (1): 23-6.
3. Herzig SJ, Howell MD, Ngo LH, Marcantonio ER. Acidsuppressive medication use and the risk for hospital-acquired pneumonia. JAMA 2009; 301 (20): 2120-8.
4. Driks MR, Craven DE, Celli BR, Manning M, Burke RA, Garvin GM, et al. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med 1987; 317 (22): 1376-82.
5. Prod'hom G, Leuenberger P, Koerfer J, Blum A, Chiolero R, Schaller MD, et al. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trial. Ann Intern Med 1994; 120 (8): 653-62.
6. Thomason MH, Payseur ES, Hakenewerth AM, Norton HJ, Mehta B, Reeves TR, et al. Nosocomial pneumonia in ventilated trauma patients during stress ulcer prophylaxis with sucralfate, antacid, and ranitidine. J Trauma 1996; 41 (3): 503-8.
7. Cook D, Walter S, Freitag A, Guyatt G, Devitt H, Meade M, et al. Adjudicating ventilator-associated pneumonia in a randomized trial of critically ill patients. J Crit Care 1998; 13 (4): 159-63.
8. Hsu TC, Su CF, Leu SC, Huang PC, Wang TE, Chu CH. Omeprazole is more effective than a histamine H2-receptor blocker for maintaining a persistent elevation of gastric pH after colon resection for cancer. Am J Surg 2004; 187 (1): 20-3.
9. Thorens J, Froehlich F, Schwizer W, Saraga E, Bille J, Gyr K, et al. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. Gut 1996; 39 (1): 54-9.
10. Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004; 292 (16): 1955-60.
11. Gulmez SE, Holm A, Frederiksen H, Jensen TG, Pedersen C, Hallas J. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based casecontrol study. Arch Intern Med 2007; 167 (9): 950-5.
12. Eurich DT, Sadowski CA, Simpson SH, Marrie TJ, Majumdar SR. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs. Am J Med 2010; 123 (1): 47-53.
13. Beaulieu M, Williamson D, Sirois C, Lachaine J. Do protonpump inhibitors increase the risk for nosocomial pneumonia in a medical intensive care unit? J Crit Care 2008; 23 (4): 513-8.
14. Miano TA, Reichert MG, Houle TT, MacGregor DA, Kincaid EH, Bowton DL. Nosocomial pneumonia risk and stress ulcer prophylaxis: a comparison of pantoprazole vs ranitidine in cardiothoracic surgery patients. Chest 2009; 136 (2): 440-7.
15. Lin PC, Chang CH, Hsu PI, Tseng PL, Huang YB. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis. Crit Care Med 2010; 38 (4): 1197-205.
16. Barletta JF, Erstad BL, Fortune JB. Stress ulcer prophylaxis in trauma patients. Crit Care 2002; 6 (6): 526-30.
17. Daschner F. Stress ulcer prophylaxis and the risk of nosocomial pneumonia in artificially ventilated patients. Eur J Clin Microbiol 1987; 6 (2): 129-31.
18. Somberg L, Morris J Jr, Fantus R, Graepel J, Field BG, Lynn R, Karlstadt R. Intermittent intravenous pantoprazole and continuous cimetidine infusion: effect on gastric pH control in critically ill patients at risk of developing stress-related mucosal disease. J Trauma 2008; 64 (5): 1202-10.
19. Levy MJ, Seelig CB, Robinson NJ, Ranney JE. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci 1997; 42 (6): 1255-9.
20. Kantorova I, Svoboda P, Scheer P, Doubek J, Rehorkova D, Bosakova H, et al. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepatogastroenterology 2004; 51 (57): 757-61.
21. Conrad SA, Gabrielli A, Margolis B, Quartin A, Hata JS, Frank WO, et al. Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med 2005; 33 (4): 760-5.
22. Fohl AL, Regal RE. Proton pump inhibitor-associated pneumonia: Not a breath of fresh air after all? World J Gastrointest Pharmacol Ther 2011; 2 (3): 17-26.
23. Prescott HC, O'Brien JM. Prevention of ventilator-associated pneumonia in adults. F1000 Med Rep 2010; 2. pii: 15.
24. Quenot JP, Thiery N, Barbar S. When should stress ulcer prophylaxis be used in the ICU? Curr Opin Crit Care 2009; 15 (2): 139-43.